Cite
Pyrzynska B, Dwojak M, Zerrouqi A, et al. FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. Oncoimmunology. 2018;7(5):e1423183doi: 10.1080/2162402X.2017.1423183.
Pyrzynska, B., Dwojak, M., Zerrouqi, A., Morlino, G., Zapala, P., Miazek, N., Zagozdzon, A., Bojarczuk, K., Bobrowicz, M., Siernicka, M., Machnicki, M. M., Gobessi, S., Barankiewicz, J., Lech-Maranda, E., Efremov, D. G., Juszczynski, P., Calado, D., Golab, J., & Winiarska, M. (2018). FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. Oncoimmunology, 7(5), e1423183. https://doi.org/10.1080/2162402X.2017.1423183
Pyrzynska, Beata, et al. "FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy." Oncoimmunology vol. 7,5 (2018): e1423183. doi: https://doi.org/10.1080/2162402X.2017.1423183
Pyrzynska B, Dwojak M, Zerrouqi A, Morlino G, Zapala P, Miazek N, Zagozdzon A, Bojarczuk K, Bobrowicz M, Siernicka M, Machnicki MM, Gobessi S, Barankiewicz J, Lech-Maranda E, Efremov DG, Juszczynski P, Calado D, Golab J, Winiarska M. FOXO1 promotes resistance of non-Hodgkin lymphomas to anti-CD20-based therapy. Oncoimmunology. 2018 Jan 25;7(5):e1423183. doi: 10.1080/2162402X.2017.1423183. eCollection 2018. PMID: 29721381; PMCID: PMC5927521.
Copy
Download .nbib